Daly City, CA, United States of America

Brandon Kwan-Leong

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Seer, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brandon Kwan-Leong. Retrieved from https://idiyas.com/inventor/brandon-kwan-leong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Brandon Kwan-Leong

Introduction

Brandon Kwan-Leong is a notable inventor based in Daly City, CA. He has made significant contributions to the field of sample preparation and protein analysis, holding a total of five patents. His work focuses on developing advanced diagnostic tools and therapeutic agents.

Latest Patents

Brandon's latest patents include systems and methods for sample preparation, data generation, and protein corona analysis. These innovations describe automated sample preparation and processing of protein corona, highlighting their application in discovering advanced diagnostic tools and therapeutic agents.

Career Highlights

Brandon is currently employed at Seer, Inc., where he continues to push the boundaries of innovation in his field. His expertise in sample preparation and protein analysis has positioned him as a key player in the development of new diagnostic technologies.

Collaborations

Some of his notable coworkers include William Manning and Young Kim, who collaborate with him on various projects at Seer, Inc. Their combined efforts contribute to the advancement of innovative solutions in the industry.

Conclusion

Brandon Kwan-Leong's work exemplifies the spirit of innovation in the field of sample preparation and protein analysis. His contributions are paving the way for new diagnostic tools and therapeutic agents that could significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…